Silver-positive kidney AL amyloidosis
J Nephrol. 2024 Jan 22. doi: 10.1007/s40620-023-01827-1. Online ahead of print.NO ABSTRACTPMID:38252262 | DOI:10.1007/s40620-023-01827-1 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 22, 2024 Category: Urology & Nephrology Authors: Francesco Fontana Gaetano Alfano Laura Verga Riccardo Magistroni Gabriele Donati Source Type: research
Epidemiology of tobacco use in dialysis patients in France and survey of nephrologists' involvement in counseling on tobacco discontinuation
CONCLUSION: Smoking cessation training for nephrologists and dedicated programs for patients in nephrology units could improve our practices and decrease the high prevalence of smoking in patients with ESKD.PMID:38253969 | DOI:10.1007/s40620-023-01842-2 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 22, 2024 Category: Urology & Nephrology Authors: Delphine Haussaire C écile Couchoud Xavier Elharrar Guy Rostoker Source Type: research
Acute kidney injury in pregnant women with decompensated liver cirrhosis, an uncommon but dangerous condition: a lesson for the clinical nephrologist
J Nephrol. 2024 Jan 19. doi: 10.1007/s40620-023-01834-2. Online ahead of print.NO ABSTRACTPMID:38240865 | DOI:10.1007/s40620-023-01834-2 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 19, 2024 Category: Urology & Nephrology Authors: Rasha Samir Shemies Tamer Zaki Gaber Mohamed Mohamed Shawqi Alaa Mosbah Nagy Sayed-Ahmed Giorgina Barbara Piccoli Source Type: research
Patient activation and psychological coping strategies to manage challenging circumstances during the COVID-19 pandemic in people with kidney disease
DISCUSSION: Those with higher activation had lower levels of anxiety, and more frequently used adaptive coping strategies during the pandemic. Targeted support and interventions may be required for people with CKD to enhance patient activation, encourage more positive adaptive coping strategies, and mitigate maladaptive coping strategies.PMID:38236468 | DOI:10.1007/s40620-023-01851-1 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Courtney Jane Lightfoot Thomas James Wilkinson Naeema Aiyub Patel Ceri Rhiannon Jones Alice Caroline Smith Source Type: research
Pregnancy-associated changes in urinary uromodulin excretion in chronic hypertension
CONCLUSIONS: In summary, we demonstrate pregnancy-associated differences in urinary uromodulin: creatinine ratio and uromodulin excretion rate between chronic hypertensive and normotensive pregnancies. Further research is needed to fully understand uromodulin physiology in human pregnancy and establish uromodulin's potential as a biomarker for renal adaptation and renal function in pregnancy.PMID:38236469 | DOI:10.1007/s40620-023-01830-6 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Sheon Mary Fran Conti-Ramsden Philipp Boder Humaira Parveen Dellaneira Setjiadi Jessica Fleminger Anna Brockbank Delyth Graham Kate Bramham Lucy Charlotte Chappell Christian Delles Source Type: research
Resistance to erythropoiesis stimulating agents in a dialysis patient after kidney graft failure
J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01836-0. Online ahead of print.NO ABSTRACTPMID:38236470 | DOI:10.1007/s40620-023-01836-0 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Silvio Borrelli Carlo Garofalo Federica Marzano Paolo Tino Ambrosino Simona Andriella Luca De Nicola Roberto Minutolo Source Type: research
Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO
J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833-3. Online ahead of print.ABSTRACTIgA nephropathy is the most common primary glomerulonephritis worldwide, and an important cause of kidney failure, as 20-40% of patients progress to renal replacement therapy 20-30 years after diagnosis. Its clinical presentation ranges from isolated microscopic hematuria to nephrotic syndrome, and even to a rapidly progressive course. Ethnicity and epigenetics play a key role in its clinical aggressiveness. Selection of patients at risk needing immunosuppressive treatment is a challenge for the nephrologist. Some active and chronic kidn...
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Hern án Trimarchi Fernando C Fervenza Rosanna Coppo Source Type: research
Women should not die of pregnancy-related acute kidney injury (PRAKI): revealing the underwater iceberg of maternal health
J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01869-5. Online ahead of print.NO ABSTRACTPMID:38236472 | DOI:10.1007/s40620-023-01869-5 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Alejandra Orozco Guill én Rasha Samir Shemies Ghada Abdulrahman Ankawi Shilpanjali Jesudason Giorgina Barbara Piccoli Source Type: research
Absolute treatment effects of novel antidiabetic drugs on a composite renal outcome: meta-analysis of digitalized individual patient data
CONCLUSION: The present meta-analysis of digitalized individual patient data revealed moderate and similar absolute treatment benefits of GLP-1 receptor agonists and SGLT2 inhibitors compared to placebo for a composite renal outcome.PMID:38236473 | DOI:10.1007/s40620-023-01858-8 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Maximilian Brockmeyer Claudio Parco Kris Gregory Vargas Ralf Westenfeld Christian Jung Malte Kelm Michael Roden Cihan Akbulut Sabrina Schlesinger Georg Wolff Oliver Kuss Source Type: research
Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project
CONCLUSION: We observed similar short-term effectiveness and safety for all potassium binders. However, treatment duration was longer for novel binders than for sodium polystyrene sulfonate.PMID:38236474 | DOI:10.1007/s40620-023-01860-0 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Ailema Gonzalez-Ortiz Catherine M Clase Alessandro Bosi Edouard L Fu Beatriz E P érez-Guillé Anne-Laure Faucon Marie Evans Carmine Zoccali Juan-Jes ús Carrero Source Type: research
Advance care planning for patients with end-stage kidney disease on dialysis: narrative review of the current evidence, and future considerations
J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01841-3. Online ahead of print.ABSTRACTPatients with end-stage kidney disease (ESKD) have a high symptom-burden and high rates of morbidity and mortality. Despite this, evidence has shown that this patient group does not have timely discussions to plan for deterioration and death, and at the end of life there are unmet palliative care needs. Advance care planning is a process that can help patients share their personal values and preferences for their future care and prepare for declining health. Earlier, more integrated and holistic advance care planning has the potential to...
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: S F Adenwalla P O'Halloran C Faull F E M Murtagh M P M Graham-Brown Source Type: research
Correction to: Clinical features suggesting renal hypouricemia as the cause of acute kidney injury: a case report and review of the literature
J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-024-01891-1. Online ahead of print.NO ABSTRACTPMID:38236476 | DOI:10.1007/s40620-024-01891-1 (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 18, 2024 Category: Urology & Nephrology Authors: Tommaso Mazzierli Luigi Cirillo Viviana Palazzo Fiammetta Ravaglia Francesca Becherucci Source Type: research
Outcomes and management of kidney transplant recipients with Fabry disease: a review
J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01853-z. Online ahead of print.ABSTRACTFabry disease is an X-linked inheritable lysosomal storage disease caused by various mutations of the galactosidase α gene resulting in α-galactosidase deficiency. Chronic kidney disease (CKD) is one of the most significant consequences of Fabry disease, with risk of end-stage kidney disease (ESKD) in this population. Like for other patients with ESKD, kidney transplant is the optimal treatment for Fabry disease patients with ESKD. However, enzyme replacement therapy and newer Fabry disease treatments remain important to mitigate other...
Source: Journal of Nephrology - January 16, 2024 Category: Urology & Nephrology Authors: Bo Yu Mohamed G Atta Daniel C Brennan Sam Kant Source Type: research
General practitioners' representation of early-stage CKD is a barrier to adequate management and patient empowerment: a phenomenological study
CONCLUSIONS: This study shows how the general practitioners' representations influence their attitudes and interventions. Clarifying the concept of early-stage CKD by taking factors like age and etiology into account would facilitate personalized management of this heterogeneous, often multimorbid, population. Finally, organizational models to support patient empowerment in an integrative care pathway must be established and validated.PMID:38227278 | DOI:10.1007/s40620-023-01838-y (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 16, 2024 Category: Urology & Nephrology Authors: Agn ès Oude Engberink Guillaume Tessier Ilham Kamil G érard Bourrel Olivier Moranne Source Type: research
The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience
CONCLUSION: Both hydroxychloroquine combined with a renin-angiotensin system inhibitor and leflunomide combined with a renin-angiotensin system inhibitor were more effective than a renin-angiotensin system inhibitor alone in improving proteinuria in IgAN patients. Hydroxychloroquine was more effective in reducing proteinuria, and leflunomide showed superiority in reducing hematuria. Our results need to be verified in large-scale randomized controlled trials.PMID:38225440 | DOI:10.1007/s40620-023-01839-x (Source: Journal of Nephrology)
Source: Journal of Nephrology - January 15, 2024 Category: Urology & Nephrology Authors: Wei-Jie He Juan Wang Nan Liu Gu-Yue Li Xin-Wang Zhu Li Yao Lin-Lin Liu Source Type: research
